<DOC>
	<DOCNO>NCT00942864</DOCNO>
	<brief_summary>The purpose study evaluate effect intravitreal Lucentis® ( Ranibizumab ) investigate anatomical functional improvement follow treatment patient macular edema due retinal vein occlusion ( RVO ) .</brief_summary>
	<brief_title>Effect Intravitreal Ranibizumab Injection With Retinal Vein Occlusion ( RVO )</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>Signed write informed consent Patients macular edema due RVO ( confirm fundus photography , fluorescein angiography , OCT ) Male female age 18 70 Baseline bestcorrected visual acuity ( BCVA ) study eye 20/400 20/30 use ETDRS chart Additional eye disease could compromise VA Ocular inflammation Intraocular surgery ≤ 1 month day 0 Uncontrolled glaucoma Prior treatment laser photocoagulation intervention macular edema due BRVO Patients age 18 71 Female patient pregnancy breast feed Not suitable regular follow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>